MedTrace Logo

Danish Breast Cancer Group Internal Mammary Node Study

NCT06549920 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7630

Last updated 2024-08-12

No results posted yet for this study

Summary

The DBCG IMN study is a nationwide prospective population-based cohort study allocating node-positive breast cancer patients with right-sided tumors to internal mammary node irradiation (IMNI) and patients with left-sided tumors to no IMNI.

Conditions

Interventions

RADIATION

Internal mammary node irradiation

Irradiation of the internal mammary nodes in intercostal space 1-4.

Sponsors & Collaborators

  • Danish Breast Cancer Cooperative Group

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-01
Primary Completion
2023-11-17
Completion
2034-01-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06549920 on ClinicalTrials.gov